Supporting The Energy Transition With Etched Metal Parts For Hydrogen And Power Electronics 
Amilia and CampDoc Announce New Integration to Simplify Registration and Health Records for Camps and Youth Programs BitNile Holdings’ Subsidiary, TurnOnGreen, to Install Commercial EV Chargers in Exclusive Bel Air Shopping Center
LAS VEGAS–(BUSINESS WIRE)–$AGH #AmosKohn—BitNile Holdings, Inc. (NYSE American: NILE), a diversified holding company (the “Company”),…
Excella Appoints Ruben Marchiani as Vice President and Market Owner of National Security
Marchiani to Drive and Accelerate Growth in the National Security Market ARLINGTON, Va.–(BUSINESS WIRE)–Excella, a…
Assured Guaranty Ltd. to Report Full Year and Fourth Quarter 2021 Financial Results on February 24, 2022
HAMILTON, Bermuda–(BUSINESS WIRE)–Assured Guaranty Ltd. (NYSE:AGO) (the Company) today announced that it will issue its…
TrailRunner International Names Jennifer Kuperman and Jen Crichton as Managing Directors
Veterans of Alibaba Group and Frito-Lay bring a combined 40+ years of corporate and agency…
Harrison Street Raises Over €800 Million in Equity for Third European Alternative Real Estate Fund, Its Largest Ever European Fund
CHICAGO & LONDON–(BUSINESS WIRE)–Harrison Street, one of the leading investment management firms exclusively focused on…
Former President of $25 Billion Corporate Pension Plan for 3M, Dennis Duerst, Joins Star Mountain Capital as a Senior Advisor
Star Mountain Capital, a private, independent, employee-owned investment manager with ~$2.5 billion AUM announced that…
Options Achieves VMware Cloud Verified Status in LD4
LONDON & NEW YORK & HONG KONG–(BUSINESS WIRE)–Options Technology, the leading Capital Markets services provider,…
USU wins Swiss canton as new customer for SAP software asset management
Möglingen, Germany – February 10, 2022 USU, the leading provider of software solutions for IT…
Immunicum AB: Invitation to Immunicum’s Full-Year 2021 Review and Pipeline and Strategy Outlook Held as a Hybrid Event on February 17, 2022
Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on the prevention of cancer recurrence…
Sosei Heptares Operational Highlights and Consolidated Results for 12 Months ended 31 December 2021
TOKYO and CAMBRIDGE, United Kingdom, Feb. 10, 2022 (GLOBE NEWSWIRE) — Sosei Group Corporation (“the…
Ultimovacs ASA: Invitation to fourth quarter 2021 results webcast presentation
Oslo, 10 February 2022: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical stage leader in immune…
Saniona Initiates Multiple Ascending Dose Stage of SAN711 Phase 1 Clinical Trial
PRESS RELEASE February 10, 2022 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on…
Data Suggest Sotrovimab Retains Neutralizing Activity Against Omicron Subvariant BA.2
– Pseudovirus results being shared with government and regulatory authorities;publication in bioRxiv anticipated in the coming…
Nexalogy Selected to Proceed to the Next Phase of Canada’s Department of National Defence Innovation for Defence Excellence and Security Project
Toronto, Ontario–(Newsfile Corp. – February 10, 2022) – Datametrex AI Limited (TSXV: DM) (FSE: D4G)…
United States: TotalEnergies to Acquire SunPower’s Commercial & Industrial Solar Business
Enabling TotalEnergies to expand reach in the U.S. B2B solar distributed generation; SunPower to focus…
Pandemic Challenges Drive EMEA Banks to FICO AI-Powered Optimisation
Akbank, and Bank Leumi are latest lenders to build lending strategies with advanced prescriptive analytics…
Infovista launches Smart CAPEX solution to deploy and scale 5G networks that deliver maximum ROI
AI/ML-based network planning, optimization, and modelling solution to deliver mobile network with the highest revenue…
FDA accepts Dupixent® (dupilumab) for Priority Review in children aged 6 months to 5 years with moderate-to-severe atopic dermatitis
FDA accepts Dupixent® (dupilumab) for Priority Review in children aged 6 months to 5 years…
argenx to Present at the 11th Annual SVB Leerink Global Healthcare Conference
February 10, 2022 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology…
Merck KGaA, Darmstadt, Germany, Enters into Option Agreement with Quris on its BioAI Platform for Clinical Safety Prediction
BOSTON and TEL-AVIV, Israel, Feb. 10, 2022 (GLOBE NEWSWIRE) — Quris, an artificial intelligence (AI)…